(Reuters) – Eli Lilly and Co said on Tuesday it expects adjusted profit in the range of $8.10 to $8.30 per share in 2023.
The adjusted profit forecast was lower than analysts’ average estimate of $9.15 per share, according to Refinitiv IBES data.
(Reporting by Leroy Leo in Bengaluru; Editing by Devika Syamnath)
